Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,490 | -8,864 | -66,369 | -51,026 | -42,630 |
| Depreciation Amortization | 833 | 555 | 3,160 | 2,356 | 1,648 |
| Income taxes - deferred | 448 | 0 | -176 | N/A | N/A |
| Accounts receivable | 359 | 167 | -555 | -1,112 | -524 |
| Other Working Capital | -155 | -1,034 | 3,538 | -752 | 48 |
| Other Operating Activity | 2,879 | 2,041 | 46,550 | 46,306 | 40,606 |
| Operating Cash Flow | $-13,126 | $-7,136 | $-13,853 | $-4,228 | $-852 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -269 | -54 | -531 | -198 | -176 |
| Net Acquisitions | N/A | N/A | 12,280 | 2,728 | N/A |
| Other Investing Activity | 0 | 0 | -5,660 | -5,219 | -2,141 |
| Investing Cash Flow | $-269 | $-54 | $6,088 | $-2,688 | $-2,317 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 221 | 0 | 667 | 223 | 223 |
| Debt Repayment | -93 | -43 | -197 | -141 | -94 |
| Common Stock Issued | 14,354 | 2,836 | 23,033 | 18,086 | 9,951 |
| Dividend Paid | N/A | N/A | -328 | -57 | -32 |
| Other Financing Activity | -103 | -87 | -14,434 | -7,689 | -1,322 |
| Financing Cash Flow | $14,379 | $2,705 | $8,742 | $10,423 | $8,727 |
| Exchange Rate Effect | N/A | N/A | 14 | -72 | -42 |
| Beginning Cash Position | 13,738 | 13,738 | 12,745 | 12,745 | 12,745 |
| End Cash Position | 14,723 | 9,254 | 13,738 | 16,180 | 18,262 |
| Net Cash Flow | $985 | $-4,484 | $992 | $3,435 | $5,516 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,126 | -7,136 | -13,853 | -4,228 | -852 |
| Capital Expenditure | -269 | -54 | -531 | -198 | -176 |
| Free Cash Flow | -13,394 | -7,189 | -14,384 | -4,425 | -1,028 |